Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Hippo signaling interactions with Wnt/Beta-catenin and Notch signaling repress liver tumorigenesis
by
Khan, Sanjoy Kumar
, Gvozdenovic-Jeremic, Jelena
, Kim, Hanjun
, Jho, Eek-hoon
, Dahlman, Jason
, Kim, Youngeun
, Kim, Wantae
, Park, Ogyi
, Ishitani, Tohru
, Yang, Yingzi
, Gao, Bin
in
Biomedical research
/ Cancer
/ Cell growth
/ Experiments
/ Gene expression
/ Kinases
/ Ligands
/ Proteins
/ Rodents
/ Transcription factors
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hippo signaling interactions with Wnt/Beta-catenin and Notch signaling repress liver tumorigenesis
by
Khan, Sanjoy Kumar
, Gvozdenovic-Jeremic, Jelena
, Kim, Hanjun
, Jho, Eek-hoon
, Dahlman, Jason
, Kim, Youngeun
, Kim, Wantae
, Park, Ogyi
, Ishitani, Tohru
, Yang, Yingzi
, Gao, Bin
in
Biomedical research
/ Cancer
/ Cell growth
/ Experiments
/ Gene expression
/ Kinases
/ Ligands
/ Proteins
/ Rodents
/ Transcription factors
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Hippo signaling interactions with Wnt/Beta-catenin and Notch signaling repress liver tumorigenesis
by
Khan, Sanjoy Kumar
, Gvozdenovic-Jeremic, Jelena
, Kim, Hanjun
, Jho, Eek-hoon
, Dahlman, Jason
, Kim, Youngeun
, Kim, Wantae
, Park, Ogyi
, Ishitani, Tohru
, Yang, Yingzi
, Gao, Bin
in
Biomedical research
/ Cancer
/ Cell growth
/ Experiments
/ Gene expression
/ Kinases
/ Ligands
/ Proteins
/ Rodents
/ Transcription factors
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Hippo signaling interactions with Wnt/Beta-catenin and Notch signaling repress liver tumorigenesis
Journal Article
Hippo signaling interactions with Wnt/Beta-catenin and Notch signaling repress liver tumorigenesis
2017
Request Book From Autostore
and Choose the Collection Method
Overview
Malignant tumors develop through multiple steps of initiation and progression, and tumor initiation is of singular importance in tumor prevention, diagnosis, and treatment. However, the molecular mechanism whereby a signaling network of interacting pathways restrains proliferation in normal cells and prevents tumor initiation is still poorly understood. Here, we have reported that the Hippo, Wnt/β-catenin, and Notch pathways form an interacting network to maintain liver size and suppress hepatocellular carcinoma (HCC). Ablation of the mammalian Hippo kinases Mst1 and Mst2 in liver led to rapid HCC formation and activated Yes-associated protein/WW domain containing transcription regulator 1 (YAP/TAZ), STAT3, Wnt/β-catenin, and Notch signaling. Previous work has shown that abnormal activation of these downstream pathways can lead to HCC. Rigorous genetic experiments revealed that Notch signaling forms a positive feedback loop with the Hippo signaling effector YAP/TAZ to promote severe hepatomegaly and rapid HCC initiation and progression. Surprisingly, we found that Wnt/β- catenin signaling activation suppressed HCC formation by inhibiting the positive feedback loop between YAP/TAZ and Notch signaling. Furthermore, we found that STAT3 in hepatocytes is dispensable for HCC formation when mammalian sterile 20-like kinase 1 and 2 (Mst1 and Mst2) were removed. The molecular network we have identified provides insights into HCC molecular classifications and therapeutic developments for the treatment of liver tumors caused by distinct genetic mutations.
Publisher
American Society for Clinical Investigation
Subject
This website uses cookies to ensure you get the best experience on our website.